The Master of Biomedical Innovation (MBI) program is a multidisciplinary, project-oriented graduate program focused on bridging the gap between technology development and its transfer into local, national, and international biomedical markets. The MBI program is projected to launch September 2023*.
By linking the theory and practice of the biomedical innovation process, the program will deliver a systematic but responsive approach to the critical, emerging discipline of innovation and entrepreneurship (I&E).
You will learn how to create and market biomedical products or devices.
You will network and learn from renowned inventors and innovators.
You will better understand emerging opportunities in therapeutics, artificial intelligence (AI), medtech, and more.
The MBI is a one-year program requiring three terms to complete. The curriculum across the year is divided into three phases and will guide learners through the biomedical innovation and entrepreneurship process.
Information Box Group
Term 1 - Biomedical problem identification and exploration
Term 2 - Solutions design and prototyping
Term 3 - Business model and pitch development
Learners will simultaneously acquire and apply the theories and skillsets presented across the three phases to a year-long, venture-orientated project.
The MBI IS unique within health sciences education and IS the
first graduate Health-care Entrepreneurship program of its kind in Canada.
The Marnix E. Heersink School of Biomedical Innovation and Entrepreneurship and the MBI program will be based in the Michael G. DeGroote Centre for Learning and Discovery. The new space is currently under construction and is projected to be completed by the program launch this fall.
Attend one of the upcoming MBI information sessions.
Information Box Group
MBI In-Person Information Session Learn More & Register
April 6, 2023 4:00 – 5:00 p.m.
MBI Virtual Information Session Learn More & Register
April 12, 2023 5:00 – 6:00 p.m.